WATCH NOW: ‘Burzynski: The Cancer Cure Cover-Up’ Documentary
Burzynski: The Cancer Cure Cover-Up is the story of a pioneering biochemist who discovered a unique and proprietary method of successfully treating most cancers.
This documentary takes the audience on a nearly 50-year journey both Dr. Burzynski and his patients have been enduring in order to obtain FDA-approved clinical trials of Antineoplastons.
Antineoplastons were discovered by Stanislaw R. Burzynski, M.D., Ph.D. in 1967 who first identified their anti-cancer properties. Antineoplastons are naturally occurring peptides demonstrating the ability to reprogram cancer cells without destroying normal cells.
Due to their low toxicity and anti-cancer activity, antineoplastons represent a revolutionary avenue in cancer research. According to Dr. Burzynski, antineoplastons are components of a complex biochemical defense system that controls cancer in the human body. Antineoplastons occur naturally in human blood and are reproduced synthetically for medicinal use.
Since their discovery in 1967, antineoplastons have been subject to extensive scientific research by the Burzynski Research Institute and many major national and international research institutes in an effort to identify their mechanism of action and use in cancer treatment.
Several institutes confirmed the anti-cancer properties of Antineoplastons, including the National Cancer Institute (1991) and Kurume University Medical School in Japan. Currently, antineoplastons are used in cancer treatment within FDA-supervised clinical trials, many of them involving patients with malignant brain tumors.
Defying the face of skepticism, legal attacks from state and federal agencies, and a powerful propaganda campaign to stop Burzynski – this doctor and his patients are still going strong. The primary reason that the cancer industry and its regulatory agencies fear the approval of Antineoplastons is purely economical. WATCH:
h/t JOS
Trackback from your site.
schutzhund
| #
It is my understanding that there are dozens of types of cancer, all arising in different organs, showing different characteristics.
And the above treatment will apply to which ones?
Reply
Frank S.
| #
Acc. to the Samid patent filing, antineoplastons will treat: neuroblastoma, acute promyelocytic leukemia, acute myelodisplasia, acute glioma, prostate cancer, breast cancer, melanoma, non small cell lung cancer, medulloblastoma and, Burkitt’s lymphoma.
Reply
Sharon Grabowski
| #
This woman STOLE with the help of insiders of the FDA, the credit away from Dr. Burzynsky. The fools couldn’ t quite tet the formulation correct. Dr. Burzynski had the patent on the rest of the product’s formula.
Reply
barry paul robinson
| #
There are symptoms that show up in a number of areas but they are all related to the blood, and one cause, toxemia being the cause of all illnesses, and cancer being the extreme.
Reply